These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23458176)
1. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. Koluman BU; Mutluay R; Derici UB; Arinsoy T; Senlik Z; Bahar B; Sancak B; Oktan SO; Sindel S Clin Nephrol; 2013 Jul; 80(1):9-16. PubMed ID: 23458176 [TBL] [Abstract][Full Text] [Related]
2. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. Kim HR; Kim SH; Han MJ; Yoon YS; Oh DJ Nephron Clin Pract; 2013; 123(3-4):165-72. PubMed ID: 23921088 [TBL] [Abstract][Full Text] [Related]
3. Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients. Liang J; Wang Z; Liu G; Zhan J; Jiang L; Jiang Z Ren Fail; 2014 Feb; 36(1):65-8. PubMed ID: 24028708 [TBL] [Abstract][Full Text] [Related]
4. The relationship between calcification inhibitor levels in chronic kidney disease and the development of atherosclerosis. Sevinc C; Yilmaz G; Ustundag S Ren Fail; 2021 Dec; 43(1):1349-1358. PubMed ID: 34583616 [TBL] [Abstract][Full Text] [Related]
5. The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients. Talib A; Nakagawa N; Saito E; Matsuki M; Kobayashi M; Akasaka K; Hirayama T; Ishida H; Sato N; Hasebe N Hypertens Res; 2012 Apr; 35(4):426-33. PubMed ID: 22129515 [TBL] [Abstract][Full Text] [Related]
6. Circulating osteoprotegerin and asymptomatic carotid atherosclerosis in postmenopausal non diabetic women. Albu A; Bondor CI; Crăciun AM; Fodor D Adv Med Sci; 2014 Sep; 59(2):293-8. PubMed ID: 25240503 [TBL] [Abstract][Full Text] [Related]
7. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. Wang ST; Xu JM; Wang M; Chen FL; Ding G Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066 [TBL] [Abstract][Full Text] [Related]
8. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis. Abdel-Wahab AF; Fathy O; Al-Harizy R Arab J Nephrol Transplant; 2013 Jan; 6(1):11-20. PubMed ID: 23282228 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial. Esteghamati A; Afarideh M; Feyzi S; Noshad S; Nakhjavani M Diabetes Metab Syndr; 2015; 9(4):258-65. PubMed ID: 25450818 [TBL] [Abstract][Full Text] [Related]
10. Association between serum fetuin-A levels, carotid artery stiffness, and intima-media thickness in patients with normotensive obstructive sleep apnea syndrome. Akyuz A; Oran M; Alpsoy S; Mutlu LC; Akkoyun DC; Guzel S; Alp R Angiology; 2014 Aug; 65(7):607-13. PubMed ID: 23892440 [TBL] [Abstract][Full Text] [Related]
11. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454 [TBL] [Abstract][Full Text] [Related]
12. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. Pateinakis P; Papagianni A; Douma S; Efstratiadis G; Memmos D BMC Nephrol; 2013 Jun; 14():122. PubMed ID: 23758931 [TBL] [Abstract][Full Text] [Related]
13. Is rationale to decrease serum osteoprotegerin and fetuin-A in type 2 diabetes mellitus patients? Berezin A Diabetes Metab Syndr; 2016; 10(3):169-70. PubMed ID: 26869171 [TBL] [Abstract][Full Text] [Related]
14. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. Anand DV; Lahiri A; Lim E; Hopkins D; Corder R J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312 [TBL] [Abstract][Full Text] [Related]
15. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy. Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023 [TBL] [Abstract][Full Text] [Related]
16. Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients. Gunes M; Temizkan S; Apaydin T; Ilgin C; Haklar G; Gogas Yavuz D J Diabetes Complications; 2021 Dec; 35(12):108073. PubMed ID: 34635402 [TBL] [Abstract][Full Text] [Related]
17. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome. Abali R; Celik C; Tasdemir N; Guzel S; Alpsoy S; Yuksel A; Celik E Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):45-9. PubMed ID: 23433744 [TBL] [Abstract][Full Text] [Related]
18. Serum osteoprotegerin level is associated with degree of arteriovenous fistula stenosis in patients with hemodialysis. Kim HR; Kim HK; Oh DJ Clin Nephrol; 2013 Nov; 80(5):322-7. PubMed ID: 24091316 [TBL] [Abstract][Full Text] [Related]
19. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686 [TBL] [Abstract][Full Text] [Related]
20. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria. Elsamahy MH; Elhenawy YI; Nawar MM J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]